huBC1-IL12, an immunocytokine which targets EDB-containing oncofetal fibronectin in tumors and tumor vasculature, shows potent anti-tumor activity in human tumor models.
Saved in:
| Title: | huBC1-IL12, an immunocytokine which targets EDB-containing oncofetal fibronectin in tumors and tumor vasculature, shows potent anti-tumor activity in human tumor models. |
|---|---|
| Authors: | Lo KM; EMD Lexigen Research Center, 45A Middlesex Turnpike, Billerica, MA 01821, USA. klo@emdlexigen.com, Lan Y, Lauder S, Zhang J, Brunkhorst B, Qin G, Verma R, Courtenay-Luck N, Gillies SD |
| Source: | Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2007 Apr; Vol. 56 (4), pp. 447-57. Date of Electronic Publication: 2006 Jul 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0340-7004 (Print) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
